Please ensure Javascript is enabled for purposes of website accessibility

Immunomedics(IMMU)

NASDAQ

IMMU
Immunomedics Stock Quote

A biopharmaceutical company focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.

Interactive Chart


News & Analysis: Immunomedics

The Fool has written over 100 articles on Immunomedics.

All

Market Moves

Earnings